0001209191-23-057548.txt : 20231205 0001209191-23-057548.hdr.sgml : 20231205 20231205185752 ACCESSION NUMBER: 0001209191-23-057548 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20231201 FILED AS OF DATE: 20231205 DATE AS OF CHANGE: 20231205 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Ansari Aseem Z. CENTRAL INDEX KEY: 0001849177 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-40288 FILM NUMBER: 231468060 MAIL ADDRESS: STREET 1: C/O DESIGN THERAPEUTICS, INC. STREET 2: 6005 HIDDEN VALLEY ROAD, SUITE 110 CITY: CARLSBAD STATE: CA ZIP: 92011 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Design Therapeutics, Inc. CENTRAL INDEX KEY: 0001807120 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 823929248 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 6005 HIDDEN VALLEY ROAD STREET 2: SUITE 110 CITY: CARLSBAD STATE: CA ZIP: 92011 BUSINESS PHONE: 858-293-4900 MAIL ADDRESS: STREET 1: 6005 HIDDEN VALLEY ROAD STREET 2: SUITE 110 CITY: CARLSBAD STATE: CA ZIP: 92011 4 1 doc4.xml FORM 4 SUBMISSION X0508 4 2023-12-01 0 0001807120 Design Therapeutics, Inc. DSGN 0001849177 Ansari Aseem Z. C/O DESIGN THERAPEUTICS, INC. 6005 HIDDEN VALLEY ROAD, SUITE 110 CARLSBAD CA 92011 0 0 1 0 0 Stock Option (right to buy) 2.51 2023-12-01 4 A 0 100000 0.00 A 2033-11-30 Common Stock 100000 100000 D The shares subject to the option will vest as follows: 25% of the shares will vest on October 1, 2024 and the balance will vest in equal monthly installments thereafter over a three year period. /s/ Mustapha Parekh, Attorney-in-Fact 2023-12-05